Menopause and Skin Changes: Why One Explanation Falls Short

On October 23, 2026, Dermatology Times published a report on skin changes during perimenopause and menopause featuring board-certified dermatologist Jacqueline Watchmaker. Her account described dryness and sensitivity alongside changes in texture and firmness, while placing those concerns within a wider picture of aging and accumulated sun exposure.

Beyond aging alone

The explanation this report moves beyond is aging alone. Ordinary aging and cumulative sun exposure remain relevant to changes in texture and firmness, according to Watchmaker’s account in Dermatology Times. Her point is that perimenopause and menopause also belong in that conversation. The broader framing adds hormonal context without replacing other explanations.

That is a shift in emphasis rather than a reason to relabel every midlife skin concern. A broader view of midlife skin physiology keeps the discussion from becoming a choice between hormones and age. For an individual woman, the useful question is how these factors fit together and what deserves attention now.

What it adds

The report’s useful details concern both the changes women describe and the way clinicians assess them. Watchmaker’s observations and recommendations include the following:

• Dryness may become more noticeable. Watchmaker described dryness as one of the concerns she hears most often. She also reported that a familiar moisturizer may no longer feel sufficient. That distinction matters because a routine can remain unchanged while the experience of using it becomes different. In an assessment, describing what feels different gives the clinician more useful information than saying only that the skin looks older or needs a stronger product.
• Sensitivity can alter product tolerance. Some patients tell Watchmaker that products they previously tolerated now irritate their skin. Her response is to reassess the existing routine for potential irritants rather than automatically add more products. The relevant change may be how the skin responds to something familiar, not simply the arrival of a new visible concern. This makes tolerance part of the conversation alongside appearance and the results a woman hopes to see.
• Texture and firmness need context. The article describes changes in texture and reduced glow alongside changes in elasticity and firmness. Watchmaker places these observations within overlapping influences from the menopausal transition and ordinary aging or accumulated sun exposure. For editorial purposes, the useful distinction is between recognizing a change and assigning its cause. A concern about firmness deserves attention without requiring a single explanation before that conversation can begin.
• Acne can return. Watchmaker described the return of acne among the concerns that may arise around perimenopause. The report discusses hormonal fluctuations as a possible association. This places breakouts within the midlife skin conversation rather than treating them as unrelated to this stage of life. The useful clinical discussion still starts with the particular change and its timing, rather than allowing the word menopause to stand in for a fuller history.
• The wider symptom picture matters. Watchmaker recommends looking beyond an isolated skin finding to menstrual changes and other systemic symptoms. That approach connects the skin concern with the person experiencing it. The purpose is not to turn a question about appearance into a hormone diagnosis. It is to give the clinician relevant background when assessing whether the menopausal transition may be part of the explanation and how the skin concern fits that broader picture.
• Routine changes should be selective. Watchmaker’s suggestions include prioritizing hydration and considering gentler active ingredients. She also advises changing a routine one step at a time and reviewing products that may be irritating. These recommendations put attention on the existing routine before expanding it. The practical emphasis is on matching care to current tolerance rather than assuming that a new midlife concern calls for an entirely new collection of products or a menopause-specific formula.
• Sun protection stays relevant. The American Academy of Dermatology (AAD) recommends broad-spectrum SPF 30 or higher on uncovered skin before going outdoors. Its menopause skin-care guidance separately addresses age spots and other signs of sun damage. This keeps sun protection in view when hormonal explanations attract most of the attention. The recommendation sits alongside an individualized assessment of dryness or sensitivity rather than depending on a clinician assigning those changes to one particular cause.

Evidence boundaries

These are observations and recommendations from a dermatologist interviewed by Dermatology Times. The article is not a new clinical trial or a formal guideline, and its routine suggestions were not tested as a treatment protocol. It cites earlier reviews without reporting new results from them.

The report provides neither a population-level estimate of these concerns nor a way to assign a precise share of an individual’s skin changes to hormones versus aging or sun exposure. It also does not establish that all adult acne in midlife is hormonal. Its contribution is an assessment framework and expert guidance, not proof that a particular routine will resolve menopause-associated skin concerns.

A useful conversation

For someone noticing a change, the research supports a straightforward starting point: note what has changed and when. Dryness and irritation are worth describing separately from a change in firmness or the return of acne. The aim is a clearer account of the concern, not a self-diagnosis.

Watchmaker’s advice also makes the existing routine relevant to that account. A product that now irritates the skin and a moisturizer that no longer feels sufficient are different observations. Both help explain what has become uncomfortable or unsatisfactory. Menstrual changes and other symptoms provide additional context for a clinician’s assessment.

Persistent or concerning symptoms belong in a discussion with a dermatologist. That conversation can address the skin concern itself rather than beginning with a presumed hormonal cause or a shopping list. Keeping realistic expectations for changing skin in view also leaves room for appearance to matter without making younger-looking skin the only acceptable outcome.

A selective approach

Watchmaker’s clearest advice about responding to increased sensitivity was that “sometimes less is more.” In the Dermatology Times interview, that comment accompanied a caution against layering numerous products onto each new concern.

The value of that advice is not that a minimal routine becomes another universal rule. It is that selectivity offers a different response to uncertainty than buying more. Within Watchmaker’s recommendations, hydration and gentler options belong alongside reviewing what is already being used.

For women whose familiar products suddenly feel unsuitable, this is a calmer way to frame the problem. The task is to understand the changed experience and discuss an appropriate adjustment, not to treat every sign of midlife as a missing product.

The practice ahead

This perspective should move midlife skin care toward fuller assessment and selective routine changes, not a default menopause label or a longer product list.

How Refemina helps

After noticing a skin change, the next task is sorting through the advice around it; Refemina translates relevant research into clear explanations of midlife health. When that advice becomes an invitation to buy supplements or pursue hormones, its coverage distinguishes credible evidence from marketing while treating appearance and confidence as legitimate parts of wellbeing.

Explore Resources

Sources

1. Menopause and the skin recognizing changes beyond aging
2. www.aad.org › public › everyday-careCaring for your skin in menopause - American Academy of ...